Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

LycorineÀÇ »ç¶÷ ±¸°­ ¾Ï ¼¼Æ÷ÁÖ¿¡¼­ survivin ´Ü¹éÁú ºÐÇØ ÁõÁøÀ¸·Î ¼¼Æ÷ÀÚ¸ê»ç À¯µµ

Lycorine induces apoptosis by enhancing protein degradation of survivin in human oral cancer cell lines

´ëÇѱ¸°­¾Ç¾È¸éº´¸®ÇÐȸÁö 2017³â 41±Ç 1È£ p.1 ~ 7
Á¤¿ä¼Á, Á¶³²Ç¥, ÀåºÐ½Ç,
¼Ò¼Ó »ó¼¼Á¤º¸
Á¤¿ä¼Á ( Jeong Joseph H. ) - ¼­¿ï´ëÇб³ ¼öÀÇ°ú´ëÇÐ ¹ßÀ°»ýÀ¯ÀüÇаú
Á¶³²Ç¥ ( Cho Nam-Po ) - ÀüºÏ´ëÇб³ Ä¡ÀÇÇдëÇпø ±¸°­º´¸®Çб³½Ç
ÀåºÐ½Ç ( Jang Boon-Sil ) - ÀüºÏ´ëÇб³ Ä¡ÀÇÇдëÇпø ±¸°­º´¸®Çб³½Ç

Abstract


Lycorine, a natural alkaloid extracted from the Amaryllidaceae plant family, was reported to various physiological and pharmacological effects including anti-cancer activity. Nevertheless, there is no report of the anticancer effect of lycorine in oral cancer cells. The effects of lycorine on cell proliferation and apoptosis were examined through trypan blue exclusion assay, 4¡¯-6-diamidino-2-phenylindole (DAPI) stain, Live/Dead assay, Western blot analysis and RT-PCR. Lycorine suppressed cell viability and induced apoptosis in MC3 and HSC-3 cell lines. Lycorine decreased survivin protein but did not affect its mRNA. It regulated survivin through accelerating protein degradation in a time-dependent manner although neither proteasome nor lysosome was not associated with lycorine-mediated protein degradation. Collectively, our results suggest that lycorine may be a potential therapeutic anti-cancer drug candidate for the treatment of human oral cancer.

Å°¿öµå

Lycorine; Apoptosis; Survivin; Human oral cancer

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

 

µîÀçÀú³Î Á¤º¸

KCI